Glycine and Glutamate
B. Bettler, C. Mulle (1995). Neurotransmitter receptors: AMPA and Kainate. Neuropharmacology
34 : 123.
H. Betz (1987). Biology and structure of the mammalian glycine receptor. Trends Neurosci. 10:
113–117.
P. Bregestovski (2002). Function, modulation and pharmacol. of inhibitory glycine receptor
channels.Neurophysiol. 34: 85–90.
M. Cascio (2002). Glycine receptors: lessons on topology and structural effects of the lipid
bilayer. Biopolymers 66: 359–368.
G. L. Collingridge (1985). Long term potentiation in the hippocampus: mechanisms of initiation
and modulation by neurotransmitters. Trends Pharmacol. Sci. 6: 407–411.
P. J. Conn, J. P. Pin (1997). Pharmacology and functions of metabotropic glutamate receptors.
Ann. Rev. Pharmacol. 37: 205.
J. R. Cooper, F. E. Bloom, R. H. Roth (1996). The Biochemical Basis ofNeuropharmacology,
7th ed. New York: Oxford University Press.
S. Daniels (2003). General anesthetic effects on glycine receptors. In: J. Antognini, E. Carstens,
D. Raines (Eds.). Neural Mechanisms of Anesthesia. Totowa, New Jersey: Humana Press,
pp. 333–344.
R. Dingledine (1986). NMDA receptors: what do they do? Trends Neurosci. 9: 47–49.
M. Hollmann, S. Heinemann (1994). Cloned glutamate receptors. Ann. Rev. Neurosci. 17: 31.
M. Jansen, G. Dannhardt (2003). Antagonists and agonists at the glycine site of the NMDA
receptor for therapeutic interventions. Eur. J. Med. Chem. 38: 661–670.
P. Krogsgaard-Larsen, T. Honore (1983). Glutamate receptors and new glutamate agonists.
Trends Pharmacol. Sci. 4: 31–33.
M. Mayer (1987). Two channels reduced to one. Nature 325: 480–481.
D. T. Monaghan, V. R. Holets, D. W. Toy, C. W. Cotman (1983). Anatomical distribution of four
pharmacologically distinct^3 H-L-glutamate binding sites. Nature 306: 176–179.
S. Nakanishi (1994). Metabotropic glutamate receptors: synaptic transmission, modulation and
plasticity. Neuron. 13: 1031.
E. J. Peck (1980). Receptors for amino acids. Annu. Rev. Physiol. 42: 615–627.
J. D. Rothstein, S. Patel, M. R. Regan, et al. (2005). β-Lactam antibiotics offer neuroprotection
by increasing glutamate transporter expression. Nature 433: 73–77.
N. A. Sharif (1985). Multiple synaptic receptors for neuroactive amino acid transmitters—new
vistas.Int. Rev. Neurobiol., vol. 26. New York: Academic Press, pp. 85–150.
Neuropeptide Neurotransmitters
S. H. Buck, E. Burcher (1986). The tachykinins: a family of peptides with a brood of ‘receptors.’
Trends Pharmacol. Sci. 7 : 65–68.
Z. Fathi (1998). Galanin receptors: recent developments and potential use as therapeutic targets.
Ann. Rep. Med. Chem. 33: 41–49.
P. J. Gilligan, P. R. Hartig, D. W. Robertson, R. Zaczek. Corticotropin-releasing hormone
receptors and discovery of selective non-peptide CRH-1 antagonists. Ann. Rep. Med. Chem.
32 : 41–50.
M. R. Hanley (1985). Substance P antagonists. In: D. Bousfield (Ed.). Neurotransmitters in
Action. Amsterdam: Elsevier, pp. 170–172.
S. G. Mills (1997). Recent advances in neurokinin receptor antagonists. Ann. Rep. Med. Chem.
32 : 51–60.
R. A. Nicoll, C. Schenker, S. E. Leeman (1980). Substance P as a transmitter candidate. Annu.
Rev. Neurosci. 3: 227–268.
308 MEDICINAL CHEMISTRY